Moleculin Biotech, Inc.
MBRX
$2.34
-$0.10-4.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.56M | -55.70M | -30.84M | -27.51M | -26.05M |
| Total Depreciation and Amortization | 90.00K | 112.00K | 122.00K | 125.00K | 126.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.18M | 33.41M | 7.43M | 3.82M | 1.83M |
| Change in Net Operating Assets | 555.00K | -278.00K | 1.95M | 1.86M | 231.00K |
| Cash from Operations | -22.74M | -22.45M | -21.34M | -21.71M | -23.86M |
| Capital Expenditure | -- | 0.00 | 0.00 | -13.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -13.00K | -13.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.29M | 19.80M | 18.08M | 12.66M | 4.66M |
| Repurchase of Common Stock | -8.00K | 0.00 | -1.00K | -26.00K | -26.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.28M | 19.80M | 18.08M | 12.63M | 4.64M |
| Foreign Exchange rate Adjustments | 51.00K | -48.00K | -28.00K | -20.00K | -32.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.60M | -2.70M | -3.29M | -9.11M | -19.27M |